| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Dariusz Madajczak, Thierry Daboval, Ryszard Lauterbach, Beata Łoniewska, Witold Błaż, Tomasz Szczapa, Iwona Sadowska-Krawczenko, Marzena Michalak-Kloc, Helena Sławska, Maria Borszewska-Kornacka, Renata Bokinie. Protocol for a multicenter, double-blind, randomized, placebo-controlled phase III trial of the inhaled β2-adrenergic receptor agonist salbutamol for transient tachypnea of the newborn (the REFSAL trial). Frontiers in pediatrics. vol 10. 2023-01-30. PMID:36714639. |
therefore, the β2-adrenergic receptor agonist salbutamol has been proposed as a treatment for ttn. |
2023-01-30 |
2023-08-14 |
Not clear |
| Dariusz Madajczak, Thierry Daboval, Ryszard Lauterbach, Beata Łoniewska, Witold Błaż, Tomasz Szczapa, Iwona Sadowska-Krawczenko, Marzena Michalak-Kloc, Helena Sławska, Maria Borszewska-Kornacka, Renata Bokinie. Protocol for a multicenter, double-blind, randomized, placebo-controlled phase III trial of the inhaled β2-adrenergic receptor agonist salbutamol for transient tachypnea of the newborn (the REFSAL trial). Frontiers in pediatrics. vol 10. 2023-01-30. PMID:36714639. |
this study aims to evaluate the efficacy and safety of salbutamol as supportive pharmacotherapy together with non-invasive nasal continuous positive airway pressure (niv/ncpap) for the prevention of persistent pulmonary hypertension of the newborn (pphn) in infants with ttn. |
2023-01-30 |
2023-08-14 |
Not clear |
| Behnaz Basiri, Nishteman Sadeghi, Mohammad Kazem Sabzehei, Farzaneh Esna Ashar. Effects of Inhaled Salbutamol on Transient Tachypnea of the Newborn. Respiratory care. 2022-03-16. PMID:34753814. |
this study aimed to evaluate the efficacy of inhaled salbutamol in ttn management. |
2022-03-16 |
2023-08-16 |
Not clear |
| Behnaz Basiri, Nishteman Sadeghi, Mohammad Kazem Sabzehei, Farzaneh Esna Ashar. Effects of Inhaled Salbutamol on Transient Tachypnea of the Newborn. Respiratory care. 2022-03-16. PMID:34753814. |
salbutamol is often suggested to increase the rate of pulmonary fluid absorption in newborns with ttn. |
2022-03-16 |
2023-08-16 |
Not clear |
| Arash Malakian, Masoud Dehdashtian, Mohammad Raza Aramesh, Mohammad Hassan Aletayeb, Solmaz Heidar. The effect of inhaled salbutamol on the outcomes of transient tachypnea of the newborn. Journal of the Chinese Medical Association : JCMA. vol 81. issue 11. 2019-06-10. PMID:30131296. |
the current study aimed to evaluate the effect of inhaled salbutamol on the clinical progression of ttn treatment. |
2019-06-10 |
2023-08-13 |
Not clear |
| Myo-Jing Kim, Jae-Ho Yoo, Jin-A Jung, Shin-Yun Byu. The effects of inhaled albuterol in transient tachypnea of the newborn. Allergy, asthma & immunology research. vol 6. issue 2. 2014-03-03. PMID:24587948. |
this study examined whether inhalational salbutamol therapy could improve clinical symptoms in ttn. |
2014-03-03 |
2023-08-12 |
Not clear |
| Didem Armangil, Murat Yurdakök, Ayşe Korkmaz, Sule Yiğit, Gülsevin Tekinal. Inhaled beta-2 agonist salbutamol for the treatment of transient tachypnea of the newborn. The Journal of pediatrics. vol 159. issue 3. 2011-11-08. PMID:21481414. |
to evaluate the efficacy of inhaled salbutamol, a beta-2 adrenergic agonist, for the treatment of transient tachypnea of the newborn (ttn) and to determine whether inhaled salbutamol is safe in newborn infants. |
2011-11-08 |
2023-08-12 |
Not clear |